Evaluation of axillary lymph nodes by diffusion-weighted MRI using ultrasmall superparamagnetic iron oxide in patients with breast cancer: Initial clinical experience

Journal of Magnetic Resonance Imaging

Volumn 34, Issue 3, 2011, Pages 557-562

  Nakai, Go ^a   Matsuki, Mitsuru ^a   Harada, Tomoaki ^a   Tanigawa, Nobuhiko ^a   Yamada, Takashi ^a   Barentsz, Jelle ^b   Narumi, Yoshifumi ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

breast cancer; lymph node; lymph node metastasis; MR lymphography; ultrasmall superparamagnetic iron oxide

Indexed keywords

ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CLINICAL ARTICLE; COMPARATIVE STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFUSION COEFFICIENT; DIFFUSION TENSOR IMAGING; DIFFUSION WEIGHTED IMAGING; FEASIBILITY STUDY; FEMALE; HUMAN; LYMPH NODE METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SENSITIVITY ANALYSIS;

ADULT; AXILLA; BREAST NEOPLASMS; CARCINOMA; CONTRAST MEDIA; DEXTRANS; FEMALE; HUMANS; LYMPHATIC METASTASIS; MAGNETITE NANOPARTICLES; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PILOT PROJECTS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 80051915997     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.22651     Document Type: Article

References (21)

1. Lyman GH, Giuliano AE, Somerfield MR, et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 2005; 23: 7703-7720. (Pubitemid 46291835)
2. Rutgers EJ, Meijnen P, Bonnefoi H,. Clinical trials update of the European Organization for Research and Treatment of Cancer Breast Cancer Group. Breast Cancer Res 2004; 6: 165-169. (Pubitemid 39136485)
3. Ichikawa T, Erturk SM, Motosugi U, et al. High-B-value diffusion-weighted MRI in colorectal cancer. AJR Am J Roentgenol 2006; 187: 181-184. (Pubitemid 46100166)
4. Nakai G, Matsuki M, Inada Y, et al. Detection and evaluation of pelvic lymph nodes in patients with gynecologic malignancies using body diffusion-weighted magnetic resonance imaging. J Comput Assist Tomogr 2008; 32: 764-768.
5. Sumi M, Van Cauteren M, Nakamura T,. MR microimaging of benign and malignant nodes in the neck. AJR Am J Roentgenol 2006; 186: 749-757. (Pubitemid 46100259)
6. Will O, Purkayastha S, Chan C, et al. Diagnostic precision of nanoparticle-enhanced MRI for lymph-node metastases: a meta-analysis. Lancet Oncol 2006; 7: 52-60. (Pubitemid 43025393)
7. Anzai Y, Piccoli CW, Outwater EK, et al. Evaluation of neck and body metastases to nodes with ferumoxtran 10-enhanced MR imaging: phase III safety and efficacy study. Radiology 2003; 228: 777-788. (Pubitemid 37025489)
8. Shaw JH, Rumball EM,. Complications and local recurrence following lymphadenectomy. Br J Surg 1990; 77: 760-764. (Pubitemid 20236114)
9. Bruneton JN, Caramella E, Hery M, Aubanel D, Manzino JJ, Picard JL,. Axillary lymph node metastases in breast cancer: preoperative detection with US. Radiology 1986; 158: 325-326. (Pubitemid 16160589)
10. Mumtaz H, Hall-Craggs MA, Davidson T, et al. Staging of symptomatic primary breast cancer with MR imaging. AJR Am J Roentgenol 1997; 169: 417-424. (Pubitemid 27334851)
11. Yoshimura G, Sakurai T, Oura S, et al. Evaluation of axillary lymph node status in breast cancer with MRI. Breast Cancer 1999; 6: 249-258.
12. Kim JK, Kim KA, Park BW, Kim N, Cho KS,. Feasibility of diffusion-weighted imaging in the differentiation of metastatic from non-metastatic lymph nodes: early experience. J Magn Reson Imaging 2008; 28: 714-719.
13. Nishimura H, Tanigawa N, Hiramatsu M, Tatsumi Y, Matsuki M, Narabayashi I,. Preoperative esophageal cancer staging: magnetic resonance imaging of lymph node with ferumoxtran-10, an ultrasmall superparamagnetic iron oxide. J Am Coll Surg 2006; 202: 604-611.
14. Tatsumi Y, Tanigawa N, Nishimura H, et al. Preoperative diagnosis of lymph node metastases in gastric cancer by magnetic resonance imaging with ferumoxtran-10. Gastric Cancer 2006; 9: 120-128. (Pubitemid 43885770)
15. Thoeny HC, Triantafyllou M, Birkhaeuser FD, et al. Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging reliably detect pelvic lymph node metastases in normal-sized nodes of bladder and prostate cancer patients. Eur Urol 2009; 55: 761-769.
16. Deserno WM, Harisinghani MG, Taupitz M, et al. Urinary bladder cancer: preoperative nodal staging with ferumoxtran-10-enhanced MR imaging. Radiology 2004; 233: 449-456. (Pubitemid 39423804)
17. Harada T, Tanigawa N, Matsuki M, Nohara T, Narabayashi I,. Evaluation of lymph node metastases of breast cancer using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging. Eur J Radiol 2007; 63: 401-407. (Pubitemid 47321038)
18. Michel SC, Keller TM, Frohlich JM, et al. Preoperative breast cancer staging: MR imaging of the axilla with ultrasmall superparamagnetic iron oxide enhancement. Radiology 2002; 225: 527-536. (Pubitemid 35239258)
19. Stets C, Brandt S, Wallis F, Buchmann J, Gilbert FJ, Heywang-Kobrunner SH,. Axillary lymph node metastases: a statistical analysis of various parameters in MRI with USPIO. J Magn Reson Imaging 2002; 16: 60-68. (Pubitemid 34700843)
20. Memarsadeghi M, Riedl CC, Kaneider A, et al. Axillary lymph node metastases in patients with breast carcinomas: assessment with nonenhanced versus uspio-enhanced MR imaging. Radiology 2006; 241: 367-377. (Pubitemid 44632881)
21. Harisinghani MG, Barentsz J, Hahn PF, et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 2003; 348: 2491-2499. (Pubitemid 36706536)